Synergy between 5-HT4 receptor activation and acetylcholinesterase inhibition in human colon and rat forestomach

Neurogastroenterology and Motility

Volumn 20, Issue 5, 2008, Pages 539-545

  Cellek, S ^a   Thangiah, R ^b   Jarvie, E M ^a   Vivekanandan, S ^b   Lalude, O ^b   Sanger, G J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

5 Hydroxytryptamine receptor; Acetylcholine; Acetylcholinesterase; Colon; Motility; Nitrergic; Stomach; Synergy

Indexed keywords

8 AMINO 7 CHLORO 1,4 BENZODIOXAN 5 CARBOXYLIC ACID 1 BUTYL 4 PIPERIDINYLMETHYL ESTER; CHOLINESTERASE INHIBITOR; NEOSTIGMINE; NITRIC OXIDE SYNTHASE INHIBITOR; PRUCALOPRIDE; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; ACETYLCHOLINESTERASE; SEROTONIN 4 RECEPTOR; SEROTONIN AGONIST;

ANIMAL TISSUE; ARTICLE; CHOLINERGIC ACTIVITY; CHOLINESTERASE INHIBITION; COLON MOTILITY; COLON MUCOSA; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ELECTRIC FIELD; FORESTOMACH; HUMAN; HUMAN TISSUE; MALE; MINIMUM INHIBITORY CONCENTRATION; MUSCLE EXCITATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; SMOOTH MUSCLE CONTRACTILITY; STOMACH MOTILITY; ANIMAL; COLON; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STOMACH;

ACETYLCHOLINESTERASE; ANIMALS; CHOLINESTERASE INHIBITORS; COLON; DRUG SYNERGISM; HUMANS; MALE; MUSCLE CONTRACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN AGONISTS; STOMACH;

EID: 42249101412     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2007.01062.x     Document Type: Article

References (18)

1. Schiller LR. New and emerging treatment options for chronic constipation. Rev Gastroenterol Disord 2004 4 (Suppl. 2 S43 51.
2. Cellek S, John AK, Thangiah R et al. 5-HT4 receptor agonists enhance both cholinergic and nitrergic activities in human isolated colon circular muscle. Neurogastroenterol Motil 2006 18:853 61.
3. Prins NH, Akkermans LM, Lefebvre RA, Schuurkes JA. 5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle. Br J Pharmacol 2000 131:927 32.
4. Kilbinger H, Wolf D. Effects of 5-HT4 receptor stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol 1992 345:270 5.
5. Althausen PL, Gupta MC, Benson DR, Jones DA. The use of neostigmine to treat postoperative ileus in orthopedic spinal patients. J Spinal Disord 2001 14:541 5.
6. Behm B, Stollman N. Postoperative ileus: etiologies and interventions. Clin Gastroenterol Hepatol 2003 1:71 80.
7. Hutchinson R, Griffiths C. Acute colonic pseudo-obstruction: a pharmacological approach. Ann R Coll Surg Engl 1992 74:364 7.
8. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999 341:137 41.
9. Stephenson BM, Morgan AR, Salaman JR, Wheeler MH. Ogilvie's syndrome: a new approach to an old problem. Dis Colon Rectum 1995 38:424 7.
10. Turegano-Fuentes F, Munoz-Jimenez F, Valle-Hernandez E et al. Early resolution of Ogilvie's syndrome with intravenous neostigmine: a simple, effective treatment. Dis Colon Rectum 1997 40:1353 7.
11. Iwanaga Y, Miyashita N, Morikawa K, Mizumoto A, Kondo Y, Itoh Z. A novel water-soluble dopamine-2 antagonist with anticholinesterase activity in gastrointestinal motor activity. Comparison with domperidone and neostigmine. Gastroenterology 1990 99:401 8.
12. Kishibayashi N, Tomaru A, Ichikawa S et al. Enhancement by KW-5092, a novel gastroprokinetic agent, of the gastrointestinal motor activity in dogs. Jpn J Pharmacol 1994 65:131 42.
13. Jarvie EM, North LV, Corcoran S, Bassil A, Sanger GJ. Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro. Br J Pharmacol 2007 150:455 62.
14. Beattie DT, Smith JA, Marquess D et al. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Br J Pharmacol 2004 143:549 60.
15. Bassil AK, Haglund Y, Brown J et al. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol 2007 150:58 64.
16. Wardle KA, Ellis ES, Baxter GS, Kennett GA, Gaster LM, Sanger GJ. The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon. Br J Pharmacol 1994 112:789 94.
17. Mizumoto A, Itoh Z. [Anti-cholinesterase activity of dopamine D2 receptor antagonist: its clinical significance]. Nippon Heikatsukin Gakkai Zasshi 1989 25:155 65.
18. Campbell-Dittmeyer K, Hicks GA, Greenwood B. A study to examine the synergistic effect of a cholinesterase inhibitor and a 5HT(4) agonist on colonic transit. Gastroenterology 2007 132:W1218.